1. Hypoxia upregulates hepatic angiopoietin-2 transcription to promote the progression of hepatocellular carcinoma
    Jun-Ling Yang et al, 2024, World Journal of Hepatology CrossRef
  2. Identification of afatinib-associated ADH1B and potential small-molecule drugs targeting ADH1B for hepatocellular carcinoma
    Yongxu Zhou et al, 2023, Frontiers in Pharmacology CrossRef
  3. MMP-9 secreted by M2-type macrophages promotes Wilms’ tumour metastasis through the PI3K/AKT pathway
    Kaixuan Tian et al, 2022, Molecular Biology Reports CrossRef
  4. Transcriptome Analysis of the Inhibitory Effect of Sennoside A on the Metastasis of Hepatocellular Carcinoma Cells
    Jiamei Le et al, 2021, Frontiers in Pharmacology CrossRef
  5. Insights into the immunomodulatory regulation of matrix metalloproteinase at the maternal-fetal interface during early pregnancy and pregnancy-related diseases
    Mengyu Jing et al, 2023, Frontiers in Immunology CrossRef

  6. Relevance of EGFR Between Serum VEGF and MMP-9 in Primary Hepatocellular Carcinoma Patients with Transarterial Chemoembolization


    Shengya Cao et al, 2020, OncoTargets and Therapy CrossRef
  7. Study on the molecular mechanism of anti-liver cancer effect of Evodiae fructus by network pharmacology and QSAR model
    Peng-Yu Chen et al, 2023, Frontiers in Chemistry CrossRef
  8. Camptothecin enhances the anti-tumor effect of low-dose apatinib combined with PD-1 inhibitor on hepatocellular carcinoma
    Hankang Wang et al, 2024, Scientific Reports CrossRef
  9. Prognosis and Personalized Treatment Prediction in Different Mutation-Signature Hepatocellular Carcinoma
    Yuyuan Zhang et al, 2023, Journal of Hepatocellular Carcinoma CrossRef
  10. EGFR is a potential dual molecular target for cancer and Alzheimer’s disease
    Hee-Jeong Choi et al, 2023, Frontiers in Pharmacology CrossRef